T1Type1Cure
A doctor checks a young girl's arm while her mother watches, emphasizing at-home healthcare.
Pavel Danilyuk (Pexels) / Pexels License
Diagnosis & Early Detection/May 13, 2026/2 min read

A Rare Genetic Condition That Causes Type 1 Diabetes and Kidney Disease

IPEX syndrome is a rare inherited disorder that can present with Type 1 diabetes in infancy along with other autoimmune and allergic symptoms. Understanding its features may help clinicians recognize it earlier.

diagnosisscreeningautoantibodiesstaging

Key takeaways

  • IPEX syndrome is caused by mutations in the FOXP3 gene and typically appears in early childhood with diarrhea, Type 1 diabetes, and skin rashes
  • Kidney disease occurs in a significant number of IPEX patients and can develop years after the initial diagnosis
  • The condition requires genetic testing to confirm and may involve multiple organ systems beyond the digestive tract
  • Early recognition is important because treatment options, including stem cell transplantation, may be considered

What Is IPEX Syndrome?

IPEX syndrome stands for X-linked immune dysregulation, polyendocrinopathy, and enteropathy syndrome. It is a rare genetic condition caused by mutations in the FOXP3 gene. The condition disrupts the body's immune system, leading to multiple organ involvement.

The classic presentation includes three main features: severe, difficult-to-treat diarrhea, Type 1 diabetes, and a skin condition resembling dermatitis. These symptoms typically appear very early in life, often in infancy or early childhood.

Beyond the Classic Symptoms

While the three hallmark symptoms are well recognized, IPEX syndrome can affect other systems in the body. In the case described here, a 15-year-old boy developed Type 1 diabetes at age one, followed by difficult-to-control asthma, eczema-like rashes, and food allergies—showing how the condition can evolve over time.

Kidney involvement has been documented in a substantial minority of IPEX patients. The most common kidney pattern observed is membranous nephropathy, though other presentations can occur. In this case, the patient developed an unusual overlap of two different kidney disease patterns.

Kidney Disease in IPEX: A Complication to Monitor

The boy in this case developed increasing creatinine levels and protein in his urine by age nine. A kidney biopsy showed features of both membranous and IgA nephropathy—two different patterns of kidney inflammation occurring together. This combination may have accelerated the decline in his kidney function.

His kidney disease progressed to stage V chronic kidney disease despite medical management. He is now awaiting hematopoietic stem cell transplantation, a treatment approach that may be considered for IPEX patients with severe organ involvement.

Why This Case Matters for Diagnosis

This case demonstrates an uncommon presentation of IPEX syndrome through its kidney involvement. Many clinicians may not immediately associate kidney disease with IPEX, especially if gastrointestinal symptoms are not prominent.

Genetic testing confirmed the diagnosis by identifying a pathogenic variant in the FOXP3 gene. Clinicians are advised to consider IPEX syndrome in children who present with kidney disease alongside autoimmune endocrine conditions (like Type 1 diabetes) or allergic features, even if the typical gastrointestinal symptoms are absent or mild.

Evidence label

Source: BMC nephrology. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.